Drugs News and Research

RSS

NIMH awards Genomas an SBIR Grant to develop MRI DNA biomarkers for neuropsychiatric disease

Genomas(R), a biomedical company advancing DNA-Guided medicine, today announced the award of a 3-year Phase II Small Business Innovation Research (SBIR) Grant totaling $1.4 Million. The grant, entitled MRI DNA Biomarkers for Neuropsychiatric Disease, was awarded by the National Institute of Mental Health.

16 Sep 2009

Generic drugs create significant cost savings

Generic drugs and mail-order systems can save health plans money since brand name drugs generally cost 50 percent to 70 percent more than generics.

16 Sep 2009

AS&E receives order for cargo X-ray inspection systems

American Science and Engineering, Inc. (AS&E®) (NASDAQ: ASEI), a leading worldwide supplier of innovative X-ray detection solutions, announced today that it has received an $18.8 million order for cargo X-ray inspection systems from an unnamed government agency to screen cargo and vehicles for explosive threats and contraband at border crossings.

16 Sep 2009

New book on pharmacology launched

Academic Press, a division of Elsevier, would like to announce the new book, Pharmacology: Principles and Practice, authored by Miles Hacker, William S. Messer, II and Kenneth A. Bachmann.

16 Sep 2009

Four H1N1 vaccines approved by FDA

The U.S. Food and Drug Administration announced today that it has approved four vaccines against the 2009 H1N1 influenza virus. The vaccines will be distributed nationally after the initial lots become available, which is expected within the next four weeks.

16 Sep 2009

eHealthInsurance's key questions to help women purchase health insurance plans

eHealthInsurance, the leading online source of health insurance for individuals, families and small businesses, today released a list of answers to questions frequently asked by women who call its customer care center. The customer care center includes a call center staffed with licensed insurance agents.

15 Sep 2009

Free medication reminder service launched for patients

Prescription medications are widely used in the U.S., with 47% of Americans using at least one prescription drug, according to the Center for Disease Control's report "Health, United States, 2008." Prescription drug use is even more widespread among the senior population, with 66% of those in the 45-65 age group and 87% of those aged 65 years and older on prescription medications.

15 Sep 2009

Council briefing series to examine role of public policy in promoting medical innovation

The Council for American Medical Innovation will host a breakfast briefing on Capitol Hill titled "Translational Research - From Bench to Bedside." Health policy experts will explore important changes needed to improve the process of development and approval for safe and effective drugs, biologics, medical devices and diagnostics.

15 Sep 2009

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has signed binding letters of intent with three partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities, as well as for marketing and distribution of peramivir for seasonal influenza upon local regulatory approval, within their territories outside the U.S.

15 Sep 2009

The University City Science Center contributes significantly to regional economy

Graduate organizations and current residents of the University City Science Center’s business incubators have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually, according to a study measuring the economic impact of the Science Center’s business incubation services that was released September 14, 2009.

15 Sep 2009

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

A study exploring the healing of diabetic skin ulcers using topical oxygen/ozone gas mixtures could not proceed to completion and was now abandoned, according to Ozonics International, LLC, a veteran-owned biotechnology company engaged in the research and development of ozone-based medical therapies.

15 Sep 2009

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering breakthrough treatments for human disease, obtained favorable results from recently completed Phase 1 studies of LX4211 and announced today that it has initiated a Phase 2 clinical trial of the drug candidate in patients with type 2 diabetes mellitus.

15 Sep 2009

AST meeting to review most recent developments in the field of organ transplantation

The American Society of Transplantation (AST) presents Transplantation: The Year in Review, Oct. 24-25, 2009 in Houston, Texas. The meeting features a review of the most recent developments in the field of organ transplantation from May 2008 up to and including the 2009 American Transplant Congress (ATC) that was held in May in Boston.

15 Sep 2009

Genova gains access to Big Pharma's distribution channels

GENova Biotherapeutics Inc. ("GENova"), a cancer drug acquisition and development company, is pleased to announce it has gained access to distribution channels for its promising drug targets through a recently-signed deal with Bridge BioResearch Plc. ("Bridge BioResearch").

15 Sep 2009

Thermo Fisher to showcase food safety solutions at AOAC 2009, Philadelphia

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is featuring its industry-leading range of instrumentation, equipment, consumables and software used for food safety testing at the AOAC International annual meeting and exposition in Philadelphia from Sept. 11-17.

From Thermo Fisher Scientific Inc. 15 Sep 2009

Pieris AG and Allergan sign collaboration agreement

Pieris AG today announced that they have entered into a collaboration agreement with Allergan, Inc. (NYSE: AGN) that combines Pieris' proprietary Anticalin technology with Allergan's expertise in drug delivery and ophthalmic drug development with a goal of developing agents for the treatment of serious ocular disorders.

15 Sep 2009

Risk for patients contracting pneumonia increases threefold when treated with pantoprazole: Study

A popular stomach-acid reducer used to prevent stress ulcers in critically ill patients needing breathing machine support increases the risk of those patients contracting pneumonia threefold, according to researchers at Wake Forest University School of Medicine.

15 Sep 2009

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Merck Sharp & Dohme Limited (MSD) announced today that ISENTRESS® (raltegravir) has been granted an expanded licence from the European Union Commission (Commission) for use in combination with other antiretroviral (ARV) medicinal products for the treatment of HIV-1 infection in adult patients, including adult patients starting HIV-1 therapy for the first time (treatment-naïve), as well as treatment-experienced adult patients.

15 Sep 2009

Antibiotics sold online without prescriptions, according to MUSC researchers

According to MUSC researchers, antibiotics are widely available for purchase on the Internet without a prescription, despite efforts to control antibiotic-resistant bacteria as a result of misuse of these drugs.

15 Sep 2009

LLS to invest in research to reduce toxic side-effects of cancer treatment

The cure rates for many cancers have improved dramatically over the past decades, but the harsh reality is that too many cancer survivors suffer serious side-effects of their curative treatments. Toxic side-effects can occur months or years after the treatments are finished, sometimes as chronic conditions, sometimes life-threatening, but always unacceptably reducing a patient's quality of life.

15 Sep 2009

Drugs News and Research

NIMH awards Genomas an SBIR Grant to develop MRI DNA biomarkers for neuropsychiatric disease

Generic drugs create significant cost savings

AS&E receives order for cargo X-ray inspection systems

New book on pharmacology launched

Four H1N1 vaccines approved by FDA

eHealthInsurance's key questions to help women purchase health insurance plans

Free medication reminder service launched for patients

Council briefing series to examine role of public policy in promoting medical innovation

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

The University City Science Center contributes significantly to regional economy

NYSDOH blocks U.S.-Egypt study of ozone-based medical therapies for diabetic skin ulcers

Lexicon initiates Phase 2 clinical trial of LX4211 in patients with type 2 diabetes mellitus

AST meeting to review most recent developments in the field of organ transplantation

Genova gains access to Big Pharma's distribution channels

Thermo Fisher to showcase food safety solutions at AOAC 2009, Philadelphia

Pieris AG and Allergan sign collaboration agreement

Risk for patients contracting pneumonia increases threefold when treated with pantoprazole: Study

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Antibiotics sold online without prescriptions, according to MUSC researchers

LLS to invest in research to reduce toxic side-effects of cancer treatment

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News